This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ott, H. W. Articles by Illmensee, K. Search for Related Content PubMed PubMed Citation Articles by Ott, H. W. Articles by Illmensee, K.

Calgranulins in Cystic Fluid and Serum from Patients with Ovarian Carcinomas¹

Department of Gynecology and Obstetrics, University Hospital of Innsbruck, Innsbruck A-6020 [H. W. O., E. M-H., B. A., A. B., S. F., P. S., A. Z., C. M., K. I.]; Department of Medical Chemistry and Biochemistry, University of Innsbruck, Innsbruck A-6020, Austria [H. L., B. S.]

Ovarian cancer remains still associated with poor prognosis because it is diagnosed predominantly at advanced stages. Ovarian-specific tumor markers do not yet exist for early detection of the disease. At the search of diagnostic markers for ovarian cancer, proteomic-based approaches have focused on novel investigations of neoplastic processes in tumor patients. Cystic fluids of malignant and benign ovarian tumors and serum from the corresponding patients were collected and processed for two-dimensional gel electrophoresis. Proteins were visualized on the gels by silver staining. At the low molecular mass level between 10 and 20 kDa, selected protein spots were additionally processed for nanospray mass spectrometry and partial amino acid sequencing. For protein identification, the sequencing results were compared with computer information from a protein data bank. Protein patterns from cystic fluids of ovarian carcinomas differed significantly from those of benign cysts and revealed additional polypeptides at low molecular mass level between 10 and 20 kDa. Protein patterns from serum of patients with malignant ovarian tumors also contained additional polypeptides between 10 and 20 kDa that were not detected in serum from patients with benign cysts. The additional proteins in serum were present in similar electrophoretic positions compared with those found in the cystic fluid of the corresponding ovarian carcinomas. Protein spots in the range of 10–20 kDa were selected for partial amino acid sequencing. Two protein spots were identified as calgranulin A and three spots as calgranulin B. Either both proteins or only calgranulin A or B were present in cystic fluid from ovarian carcinomas and serum of the corresponding patients. These two proteins were absent or not detectable in fluid from benign ovarian cysts and in serum from those patients. Our investigations concerning protein patterns in cystic fluid of malignant and benign ovarian tumors provide new information about alterations in protein synthesis linked to neoplastic events of the ovary. With the proteomic strategy, new tumor markers are characterized and may serve for diagnostic purposes of patients with ovarian cancer.

This article has been cited by other articles:

				L. Zhou, R. W. Beuerman, L. P. K. Ang, C. M. Chan, S. F. Y. Li, F. T. Chew, and D. T. H. Tan Elevation of Human {alpha}-Defensins and S100 Calcium-Binding Proteins A8 and A9 in Tear Fluid of Patients with Pterygium Invest. Ophthalmol. Vis. Sci., May 1, 2009; 50(5): 2077 - 2086. [Abstract] [Full Text] [PDF]

				A. Moon, H.-Y. Yong, J.-I. Song, D. Cukovic, S. Salagrama, D. Kaplan, D. Putt, H. Kim, A. Dombkowski, and H.-R. C. Kim Global Gene Expression Profiling Unveils S100A8/A9 as Candidate Markers in H-Ras-Mediated Human Breast Epithelial Cell Invasion Mol. Cancer Res., October 1, 2008; 6(10): 1544 - 1553. [Abstract] [Full Text] [PDF]

				A. Goncalves, E. Charafe-Jauffret, F. Bertucci, S. Audebert, Y. Toiron, B. Esterni, F. Monville, C. Tarpin, J. Jacquemier, G. Houvenaeghel, et al. Protein Profiling of Human Breast Tumor Cells Identifies Novel Biomarkers Associated with Molecular Subtypes Mol. Cell. Proteomics, August 1, 2008; 7(8): 1420 - 1433. [Abstract] [Full Text] [PDF]

				S. Ghavami, I. Rashedi, B. M. Dattilo, M. Eshraghi, W. J. Chazin, M. Hashemi, S. Wesselborg, C. Kerkhoff, and M. Los S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway J. Leukoc. Biol., June 1, 2008; 83(6): 1484 - 1492. [Abstract] [Full Text] [PDF]

				J. Furst, A. Schedlbauer, R. Gandini, M. L. Garavaglia, S. Saino, M. Gschwentner, B. Sarg, H. Lindner, M. Jakab, M. Ritter, et al. ICln159 Folds into a Pleckstrin Homology Domain-like Structure: INTERACTION WITH KINASES AND THE SPLICING FACTOR LSm4 J. Biol. Chem., September 2, 2005; 280(35): 31276 - 31282. [Abstract] [Full Text] [PDF]

				A. Hermani, J. Hess, B. De Servi, S. Medunjanin, R. Grobholz, L. Trojan, P. Angel, and D. Mayer Calcium-Binding Proteins S100A8 and S100A9 as Novel Diagnostic Markers in Human Prostate Cancer Clin. Cancer Res., July 15, 2005; 11(14): 5146 - 5152. [Abstract] [Full Text] [PDF]

				J. Shen, M. D. Person, J. Zhu, J. L. Abbruzzese, and D. Li Protein Expression Profiles in Pancreatic Adenocarcinoma Compared with Normal Pancreatic Tissue and Tissue Affected by Pancreatitis as Detected by Two-Dimensional Gel Electrophoresis and Mass Spectrometry Cancer Res., December 15, 2004; 64(24): 9018 - 9026. [Abstract] [Full Text] [PDF]

				S. Skvortsov, B. Sarg, J. Loeffler-Ragg, I. Skvortsova, H. Lindner, H. Werner Ott, P. Lukas, K. Illmensee, and H. Zwierzina Different proteome pattern of epidermal growth factor receptor-positive colorectal cancer cell lines that are responsive and nonresponsive to C225 antibody treatment Mol. Cancer Ther., December 1, 2004; 3(12): 1551 - 1558. [Abstract] [Full Text] [PDF]